These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6120959)

  • 1. Drug-induced extrapyramidal disorders - a neuropsychiatric interface.
    Goetz CG; Klawans HL
    J Clin Psychopharmacol; 1981 Sep; 1(5):297-303. PubMed ID: 6120959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.
    Marsden CD; Jenner P
    Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapyramidal side effects of antipsychotic medications.
    Harris E
    Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762
    [No Abstract]   [Full Text] [Related]  

  • 5. Extrapyramidal side-effects.
    Bürki HR
    Pharmacol Ther B; 1979; 5(1-3):525-34. PubMed ID: 40265
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.
    Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A
    Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
    Tarsy D
    Clin Neuropharmacol; 1983; 6 Suppl 1():S9-26. PubMed ID: 6139168
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine in the management of extrapyramidal side effects.
    Borison RL
    Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167
    [No Abstract]   [Full Text] [Related]  

  • 10. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological mechanisms underlying tardive dyskinesia.
    Gerlach J
    Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorting through EPS (extrapyramidal symptoms).
    Blair DT
    Geriatr Nurs; 1991; 12(5):244-6. PubMed ID: 1687319
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical mechanisms and management of choreiform movement disorders.
    de Silva L
    Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic associated extrapyramidal symptoms.
    Maurer I; Zierz S; Möller HJ; Jerusalem F
    Br J Psychiatry; 1995 Oct; 167(4):551-2. PubMed ID: 8829733
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects of antipsychotic drugs.
    Malhotra AK; Litman RE; Pickar D
    Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.